Literature DB >> 17977969

Paramyxovirus-induced shutoff of host and viral protein synthesis: role of the P and V proteins in limiting PKR activation.

Maria D Gainey1, Patrick J Dillon, Kimberly M Clark, Mary J Manuse, Griffith D Parks.   

Abstract

The paramyxovirus simian virus 5 (SV5) establishes highly productive persistent infections of epithelial cells without inducing a global inhibition of translation. Here we show that an SV5 mutant (the P/V-CPI(-) mutant) with substitutions in the P subunit of the viral polymerase and the accessory V protein also establishes highly productive infections like wild-type (WT) SV5 but that cells infected with the P/V-CPI(-) mutant show an overall shutdown of both host and viral translation at late times postinfection. Reduced host and viral protein synthesis with the P/V-CPI(-) virus was not due to lower levels of mRNA or caspase-dependent apoptosis and correlated with phosphorylation of the translation initiation factor eIF-2alpha. WT SV5 was a poor activator of the eIF-2alpha kinase protein kinase R (PKR). By contrast, the P/V-CPI(-) mutant induced PKR phosphorylation, which correlated with the time course of translation inhibition but was independent of interferon signaling. In HeLa cells that expressed the PKR inhibitor influenza A virus NS1 or reovirus sigma3, the rate of host protein synthesis at late times after infection with the P/V-CPI(-) mutant was restored to approximately 50% that of control HeLa cells. By contrast, the rates of P/V-CPI(-) viral protein synthesis in HeLa cells expressing NS1 or sigma3 were dramatically enhanced, between 5- and 20-fold, while levels of viral mRNA were increased only slightly (NS1-expressing cells) or remained constant (sigma3-expressing cells). Similar results were found using HeLa cells where PKR levels were reduced due to knockdown by small interfering RNA. Expression of either the WT P or the WT V protein from the genome of the P/V-CPI(-) mutant resulted in lower levels of PKR activation and rates of host and viral protein synthesis that closely matched those seen with WT SV5. Despite higher rates of translation, cells infected with the V- or P-complemented virus accumulated viral mRNAs to lower levels than that seen with the parental P/V-CPI(-) mutant. We present a model in which the paramyxovirus P/V gene products limit induction of PKR by limiting the synthesis of aberrant viral mRNAs and double-stranded RNA and thus prevent the shutdown of translation by a mechanism that differs from that of other PKR inhibitors such as NS1 and sigma3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17977969      PMCID: PMC2224604          DOI: 10.1128/JVI.02023-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Sendai virus defective-interfering genomes and the activation of interferon-beta.

Authors:  Laura Strahle; Dominique Garcin; Daniel Kolakofsky
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

2.  A novel role for viral-defective interfering particles in enhancing dendritic cell maturation.

Authors:  Jacob S Yount; Thomas A Kraus; Curt M Horvath; Thomas M Moran; Carolina B López
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

3.  Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.

Authors:  Shoudong Li; Ji-Young Min; Robert M Krug; Ganes C Sen
Journal:  Virology       Date:  2006-02-08       Impact factor: 3.616

4.  NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I.

Authors:  Zhu Guo; Li-mei Chen; Hui Zeng; Jorge A Gomez; Julie Plowden; Takashi Fujita; Jacqueline M Katz; Ruben O Donis; Suryaprakash Sambhara
Journal:  Am J Respir Cell Mol Biol       Date:  2006-10-19       Impact factor: 6.914

5.  Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1.

Authors:  Morgan Hakki; Emily E Marshall; Katherine L De Niro; Adam P Geballe
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

6.  Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

7.  Variants of the paramyxovirus Simian virus 5 with accelerated or delayed viral gene expression activate proinflammatory cytokine synthesis.

Authors:  Virginia A Young; Patrick J Dillon; Griffith D Parks
Journal:  Virology       Date:  2006-02-15       Impact factor: 3.616

8.  mda-5, but not RIG-I, is a common target for paramyxovirus V proteins.

Authors:  Kay Childs; Nicola Stock; Craig Ross; Jelena Andrejeva; Louise Hilton; Michael Skinner; Richard Randall; Stephen Goodbourn
Journal:  Virology       Date:  2006-10-16       Impact factor: 3.616

Review 9.  Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.

Authors:  M A García; J Gil; I Ventoso; S Guerra; E Domingo; C Rivas; M Esteban
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

10.  A plasmid-based reverse genetics system for animal double-stranded RNA viruses.

Authors:  Takeshi Kobayashi; Annukka A R Antar; Karl W Boehme; Pranav Danthi; Elizabeth A Eby; Kristen M Guglielmi; Geoffrey H Holm; Elizabeth M Johnson; Melissa S Maginnis; Sam Naik; Wesley B Skelton; J Denise Wetzel; Gregory J Wilson; James D Chappell; Terence S Dermody
Journal:  Cell Host Microbe       Date:  2007-04-19       Impact factor: 21.023

View more
  38 in total

Review 1.  The regulation of type I interferon production by paramyxoviruses.

Authors:  Stephen Goodbourn; Richard E Randall
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 2.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

3.  The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection.

Authors:  Megan E Spurgeon; David A Ornelles
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

4.  Targeting viral dsRNA for antiviral prophylaxis.

Authors:  Zhou Fei; Yang Liu; Zhen Yan; Daiming Fan; Alice Alexander; Jing-Hua Yang
Journal:  FASEB J       Date:  2009-10-30       Impact factor: 5.191

Review 5.  Zoonotic Potential of Emerging Paramyxoviruses: Knowns and Unknowns.

Authors:  Patricia A Thibault; Ruth E Watkinson; Andres Moreira-Soto; Jan F Drexler; Benhur Lee
Journal:  Adv Virus Res       Date:  2017-02-02       Impact factor: 9.937

6.  Measles virus circumvents the host interferon response by different actions of the C and V proteins.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Yuta Shirogane; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction.

Authors:  M J Killip; D F Young; D Gatherer; C S Ross; J A L Short; A J Davison; S Goodbourn; R E Randall
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

8.  TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5.

Authors:  Mary J Manuse; Griffith D Parks
Journal:  Virology       Date:  2009-11-30       Impact factor: 3.616

9.  Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function.

Authors:  Subhashini Arimilli; John B Johnson; Kimberly M Clark; Aaron H Graff; Martha A Alexander-Miller; Steven B Mizel; Griffith D Parks
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1 expression and phosphorylation.

Authors:  Andrew K Hastings; Katherine R Amato; Sherry C Wen; Laura S Peterson; John V Williams
Journal:  Virology       Date:  2016-04-27       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.